If exro cannot stop the bleeding, partners would have the Second thought, who would sign NDA or deal with a company with expenses of over $100 Mln, with market cap of a little over $100 Mln, and interest rate of 12% of borrowing rate.
Hope the institution Al investors would step up to change the management, the current one simply cannot be trusted